|
LOC100271831 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.458400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.004760E-01 |
| Normal-vs-Stage2 |
3.385200E-01 |
| Normal-vs-Stage3 |
4.950000E-02 |
| Normal-vs-Stage4 |
1.750840E-01 |
| Stage1-vs-Stage2 |
9.727000E-01 |
| Stage1-vs-Stage3 |
3.898200E-01 |
| Stage1-vs-Stage4 |
8.603400E-01 |
| Stage2-vs-Stage3 |
6.138600E-01 |
| Stage2-vs-Stage4 |
9.036800E-01 |
| Stage3-vs-Stage4 |
3.567200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.934500E-02 |
| Normal-vs-AfricanAmerican |
4.434000E-01 |
| Normal-vs-Asian |
1.024360E-01 |
| Caucasian-vs-AfricanAmerican |
6.876800E-01 |
| Caucasian-vs-Asian |
9.080000E-01 |
| AfricanAmerican-vs-Asian |
5.965600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.864400E-02 |
| Normal-vs-Female |
7.009700E-02 |
| Male-vs-Female |
8.943400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.570200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.808200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.368380E-01 |
| Normal-vs-Age(81-100Yrs) |
4.792800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.012600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.530000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.155400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.652200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.512600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.692800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.269600E-01 |
| Classical-VS-Follicular |
4.587000E-01 |
| Classical-VS-Other |
5.056800E-01 |
| Classical-VS-Normal |
1.405020E-01 |
| Tall-VS-Follicular |
6.211000E-01 |
| Tall-VS-Other |
9.771000E-01 |
| Tall-VS-Normal |
1.958970E-01 |
| Follicular-VS-Other |
7.168400E-01 |
| Follicular-VS-Normal |
8.925600E-02 |
| Other-VS-Normal |
1.891610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.820000E-02 |
| Normal-vs-N1 |
4.258200E-02 |
| N0-vs-N1 |
3.435200E-01 |
|
|
